JP2020180141A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020180141A5 JP2020180141A5 JP2020117607A JP2020117607A JP2020180141A5 JP 2020180141 A5 JP2020180141 A5 JP 2020180141A5 JP 2020117607 A JP2020117607 A JP 2020117607A JP 2020117607 A JP2020117607 A JP 2020117607A JP 2020180141 A5 JP2020180141 A5 JP 2020180141A5
- Authority
- JP
- Japan
- Prior art keywords
- therapy
- composition
- tlves
- tms
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002560 therapeutic procedure Methods 0.000 claims 40
- 239000000203 mixture Substances 0.000 claims 32
- 238000011491 transcranial magnetic stimulation Methods 0.000 claims 30
- 239000005557 antagonist Substances 0.000 claims 15
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 claims 12
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 claims 12
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 claims 7
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical group C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 claims 5
- 229960003299 ketamine Drugs 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 230000037452 priming Effects 0.000 claims 5
- 210000003625 skull Anatomy 0.000 claims 5
- 230000000638 stimulation Effects 0.000 claims 5
- 210000003205 muscle Anatomy 0.000 claims 2
- 208000020925 Bipolar disease Diseases 0.000 claims 1
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 claims 1
- 208000013586 Complex regional pain syndrome type 1 Diseases 0.000 claims 1
- 206010013654 Drug abuse Diseases 0.000 claims 1
- 241000720950 Gluta Species 0.000 claims 1
- 201000001947 Reflex Sympathetic Dystrophy Diseases 0.000 claims 1
- 208000009205 Tinnitus Diseases 0.000 claims 1
- 208000028683 bipolar I disease Diseases 0.000 claims 1
- 208000025307 bipolar depression Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 208000011117 substance-related disease Diseases 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022161851A JP2022188221A (ja) | 2012-11-25 | 2022-10-06 | 視床皮質律動異常の処置 |
| JP2024208873A JP2025029043A (ja) | 2012-11-25 | 2024-11-29 | 視床皮質律動異常の処置 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261729625P | 2012-11-25 | 2012-11-25 | |
| US61/729,625 | 2012-11-25 | ||
| US13/826,250 | 2013-03-14 | ||
| US13/826,250 US8974365B2 (en) | 2012-11-25 | 2013-03-14 | Treatment of thalamocortical dysrhythmia |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018229815A Division JP2019065021A (ja) | 2012-11-25 | 2018-12-07 | 視床皮質律動異常の処置 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022161851A Division JP2022188221A (ja) | 2012-11-25 | 2022-10-06 | 視床皮質律動異常の処置 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020180141A JP2020180141A (ja) | 2020-11-05 |
| JP2020180141A5 true JP2020180141A5 (enExample) | 2021-03-11 |
Family
ID=50773848
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015544133A Pending JP2016501865A (ja) | 2012-11-25 | 2013-11-21 | 視床皮質律動異常の処置 |
| JP2018229815A Pending JP2019065021A (ja) | 2012-11-25 | 2018-12-07 | 視床皮質律動異常の処置 |
| JP2020117607A Pending JP2020180141A (ja) | 2012-11-25 | 2020-07-08 | 視床皮質律動異常の処置 |
| JP2022161851A Pending JP2022188221A (ja) | 2012-11-25 | 2022-10-06 | 視床皮質律動異常の処置 |
| JP2024208873A Pending JP2025029043A (ja) | 2012-11-25 | 2024-11-29 | 視床皮質律動異常の処置 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015544133A Pending JP2016501865A (ja) | 2012-11-25 | 2013-11-21 | 視床皮質律動異常の処置 |
| JP2018229815A Pending JP2019065021A (ja) | 2012-11-25 | 2018-12-07 | 視床皮質律動異常の処置 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022161851A Pending JP2022188221A (ja) | 2012-11-25 | 2022-10-06 | 視床皮質律動異常の処置 |
| JP2024208873A Pending JP2025029043A (ja) | 2012-11-25 | 2024-11-29 | 視床皮質律動異常の処置 |
Country Status (10)
| Country | Link |
|---|---|
| US (5) | US8974365B2 (enExample) |
| EP (2) | EP3915551A1 (enExample) |
| JP (5) | JP2016501865A (enExample) |
| KR (5) | KR20150091323A (enExample) |
| CN (1) | CN104981265A (enExample) |
| CA (1) | CA2896568C (enExample) |
| ES (1) | ES2882619T3 (enExample) |
| IL (2) | IL273912B2 (enExample) |
| MX (1) | MX2015006444A (enExample) |
| WO (1) | WO2014081948A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10155114B2 (en) * | 2014-06-03 | 2018-12-18 | Dirk De Ridder | Systems and methods of treating a neurological disorder in a patient |
| US10118038B2 (en) * | 2015-03-24 | 2018-11-06 | Dirk De Ridder | Methods of neuromodulation |
| US10201708B2 (en) | 2014-10-29 | 2019-02-12 | Dirk De Ridder | Method of treating a neurological disorder using network stimulation |
| EP3416723A4 (en) * | 2016-02-21 | 2019-07-17 | Tech Innosphere Engineering Ltd. | NONINVASIVE ELECTRICAL BRAIN STIMULATION SYSTEM |
| US10596378B2 (en) * | 2016-10-18 | 2020-03-24 | Joseph Rustick | Method for treatment of depression using synaptic pathway training |
| US10905897B2 (en) * | 2016-10-20 | 2021-02-02 | Neuro-Laser Foundation, Inc. | Synergistic treatment methodologies using light therapy |
| US9950189B1 (en) * | 2016-10-20 | 2018-04-24 | Neuro-Laser Foundation Inc. | Treatment methodologies using light therapy |
| WO2019060298A1 (en) | 2017-09-19 | 2019-03-28 | Neuroenhancement Lab, LLC | METHOD AND APPARATUS FOR NEURO-ACTIVATION |
| JP7034314B2 (ja) * | 2017-11-22 | 2022-03-11 | 潔欣 林 | うつ病を予防または治療するための安息香酸またはその塩および誘導体 |
| US11717686B2 (en) | 2017-12-04 | 2023-08-08 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to facilitate learning and performance |
| KR102099200B1 (ko) * | 2017-12-18 | 2020-04-09 | 서울대학교산학협력단 | 뇌 자극 장치 |
| PT3505157T (pt) | 2017-12-29 | 2022-02-18 | Celon Pharma Sa | Composição de cetamina em pó seco para administração pulmonar em depressão resistente ao tratamento |
| US11273283B2 (en) | 2017-12-31 | 2022-03-15 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to enhance emotional response |
| US12280219B2 (en) | 2017-12-31 | 2025-04-22 | NeuroLight, Inc. | Method and apparatus for neuroenhancement to enhance emotional response |
| US11364361B2 (en) | 2018-04-20 | 2022-06-21 | Neuroenhancement Lab, LLC | System and method for inducing sleep by transplanting mental states |
| US11452839B2 (en) | 2018-09-14 | 2022-09-27 | Neuroenhancement Lab, LLC | System and method of improving sleep |
| CN109481845B (zh) * | 2018-12-28 | 2022-04-01 | 深圳先进技术研究院 | 一种作用于不同脑区的经颅磁刺激的方法和相关装置 |
| CN110064117B (zh) * | 2019-03-27 | 2021-06-01 | 佛山职业技术学院 | 一种基于呐喊声音的心理宣泄交互方法及装置 |
| JP7413357B2 (ja) | 2019-03-28 | 2024-01-15 | 住友建機株式会社 | ショベル及び施工システム |
| US11786694B2 (en) | 2019-05-24 | 2023-10-17 | NeuroLight, Inc. | Device, method, and app for facilitating sleep |
| US12059565B1 (en) * | 2019-12-19 | 2024-08-13 | Washington University | Methods and systems for modulating unconsciousness or anesthesia in a subject |
| CN113041501A (zh) * | 2021-03-22 | 2021-06-29 | 东南大学 | 联合磁刺激系统靶向视觉皮层快速抗抑郁的方法 |
| WO2022235576A1 (en) * | 2021-05-03 | 2022-11-10 | Wang Michael Z | Methods and compositions for treating depression |
| ES2994763B2 (es) * | 2023-07-25 | 2025-11-03 | Nauta Technomedical Res S L | Sistema de neuroestimulacion magnetica hiperbarica con ajuste parametrico semi automatico personalizable |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5084007A (en) * | 1989-08-11 | 1992-01-28 | Malin David H | Method for chemical promotion of the effects of low current transcranial electrostimulation |
| US6132361A (en) * | 1994-11-28 | 2000-10-17 | Neotonus, Inc. | Transcranial brain stimulation |
| US5763393A (en) | 1996-05-17 | 1998-06-09 | Neurotherapeutics L.P. | Neuroactive peptides |
| US6176242B1 (en) * | 1999-04-30 | 2001-01-23 | Medtronic Inc | Method of treating manic depression by brain infusion |
| US6591138B1 (en) * | 2000-08-31 | 2003-07-08 | Neuropace, Inc. | Low frequency neurostimulator for the treatment of neurological disorders |
| US20110307029A1 (en) * | 2008-08-06 | 2011-12-15 | Cerephex Corporation | Brain stimulation methods for treating central sensitivity |
| US7687080B2 (en) * | 2002-11-25 | 2010-03-30 | Taraxos Inc. | Treatment of neuropathy |
| US8052591B2 (en) * | 2006-05-05 | 2011-11-08 | The Board Of Trustees Of The Leland Stanford Junior University | Trajectory-based deep-brain stereotactic transcranial magnetic stimulation |
| AU2005286733B2 (en) | 2004-09-23 | 2009-11-05 | Alexander Michalow | Methods for regulating neurotransmitter systems by inducing counteradaptations |
| EP1827580A1 (en) * | 2004-10-21 | 2007-09-05 | Advanced Neuromodulation Systems, Inc. | New stimulation design for neuromodulation |
| CN101686945A (zh) * | 2004-11-23 | 2010-03-31 | 埃德莫斯药品有限公司 | 包含持续释放的包衣或基质和nmda受体拮抗剂的组合物，以及向受治疗者施用该nmda受体拮抗剂的方法 |
| US7619007B2 (en) * | 2004-11-23 | 2009-11-17 | Adamas Pharmaceuticals, Inc. | Method and composition for administering an NMDA receptor antagonist to a subject |
| US8676330B2 (en) * | 2009-03-20 | 2014-03-18 | ElectroCore, LLC | Electrical and magnetic stimulators used to treat migraine/sinus headache and comorbid disorders |
| CN101432011A (zh) * | 2006-02-27 | 2009-05-13 | 亚历山大·米哈洛 | 通过诱导逆适应调节神经递质系统的方法 |
| WO2007103475A2 (en) * | 2006-03-07 | 2007-09-13 | Beth Israel Deaconess Medical Center, Inc. | Transcranial magnetic stimulation (tms) methods and apparatus |
| AU2007229866A1 (en) * | 2006-03-22 | 2007-10-04 | Mount Sinai School Of Medicine | Intranasal administration of ketamine to treat depression |
| US7949403B2 (en) * | 2007-02-27 | 2011-05-24 | Accelerated Care Plus Corp. | Electrical stimulation device and method for the treatment of neurological disorders |
| CN102762207A (zh) * | 2008-05-09 | 2012-10-31 | 爱莫里大学 | 用于治疗神经精神疾患的nmda受体拮抗剂 |
| ES2736276T3 (es) * | 2008-07-14 | 2019-12-27 | Arizona Board Of Regents For And On Behalf Of Arizona State Univ | Dispositivos de modulación de la actividad celular utilizando ultrasonido |
| EP2321007B1 (en) * | 2008-08-04 | 2016-10-12 | The Trustees of Columbia University in the City of New York | Apparatus and systems for magnetic stimulation |
| US8674095B2 (en) | 2008-12-19 | 2014-03-18 | Afraxis Holdings, Inc. | Compounds for treating neuropsychiatric conditions |
| US9067052B2 (en) | 2009-03-02 | 2015-06-30 | Yeda Research And Development Co., Ltd. At The Weizmann Institute Of Science | Magnetic configuration and timing scheme for transcranial magnetic stimulation |
| US8951968B2 (en) | 2009-10-05 | 2015-02-10 | Northwestern University | Methods of treating depression and other related diseases |
| JP2013507395A (ja) * | 2009-10-09 | 2013-03-04 | アフラクシス・インコーポレイテッド | Ｃｎｓ障害治療用の８−エチル−６−（アリール）ピリド［２，３−ｄ］ピリミジン−７（８ｈ）−オン |
| CA2784119A1 (en) * | 2009-12-15 | 2011-06-23 | Neurop, Inc. | Compounds for the treatment of neurologic disorders |
| WO2011123548A2 (en) * | 2010-04-02 | 2011-10-06 | Neostim, Inc | Neuromodulation of deep-brain targets by transcranial magnetic stimulation enhanced by transcranial direct current stimulation |
| US20140058189A1 (en) * | 2012-02-20 | 2014-02-27 | William F. Stubbeman | Systems and methods using brain stimulation for treating disorders |
-
2013
- 2013-03-14 US US13/826,250 patent/US8974365B2/en active Active
- 2013-11-21 ES ES13856126T patent/ES2882619T3/es active Active
- 2013-11-21 KR KR1020157015152A patent/KR20150091323A/ko not_active Ceased
- 2013-11-21 KR KR1020227032393A patent/KR20220132667A/ko not_active Ceased
- 2013-11-21 IL IL273912A patent/IL273912B2/en unknown
- 2013-11-21 CN CN201380069664.7A patent/CN104981265A/zh active Pending
- 2013-11-21 MX MX2015006444A patent/MX2015006444A/es unknown
- 2013-11-21 WO PCT/US2013/071275 patent/WO2014081948A1/en not_active Ceased
- 2013-11-21 KR KR1020207028289A patent/KR20200117062A/ko not_active Ceased
- 2013-11-21 KR KR1020257009861A patent/KR20250046361A/ko active Pending
- 2013-11-21 EP EP21172714.4A patent/EP3915551A1/en active Pending
- 2013-11-21 EP EP13856126.1A patent/EP2922591B1/en active Active
- 2013-11-21 JP JP2015544133A patent/JP2016501865A/ja active Pending
- 2013-11-21 KR KR1020237031477A patent/KR20230141875A/ko not_active Ceased
- 2013-11-21 CA CA2896568A patent/CA2896568C/en active Active
-
2015
- 2015-02-27 US US14/634,305 patent/US9649501B2/en active Active
- 2015-05-21 IL IL238979A patent/IL238979B/en active IP Right Grant
-
2017
- 2017-04-19 US US15/491,612 patent/US10716950B2/en active Active
-
2018
- 2018-12-07 JP JP2018229815A patent/JP2019065021A/ja active Pending
-
2020
- 2020-07-08 JP JP2020117607A patent/JP2020180141A/ja active Pending
- 2020-07-20 US US16/933,397 patent/US20210101015A1/en not_active Abandoned
-
2022
- 2022-10-06 JP JP2022161851A patent/JP2022188221A/ja active Pending
-
2023
- 2023-09-05 US US18/461,499 patent/US20240207630A1/en active Pending
-
2024
- 2024-11-29 JP JP2024208873A patent/JP2025029043A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020180141A5 (enExample) | ||
| JP2016501865A5 (enExample) | ||
| JP2022188221A (ja) | 視床皮質律動異常の処置 | |
| Zhang et al. | Research advances in the clinical application of esketamine | |
| JP2007500238A5 (enExample) | ||
| IL315023A (en) | Neuroactive steroids for treatment of cns-related disorders | |
| JP2010535805A5 (enExample) | ||
| CN106562952B (zh) | 氯胺酮在治疗重性抑郁障碍中的应用 | |
| JP2013518124A5 (enExample) | ||
| JP2018529766A5 (enExample) | ||
| RU2012108656A (ru) | Применение 4-аминопиридина для улучшения состояния при нейрокогнитивном и/или нейропсихиатрическом нарушении у пациентов с демиелинизирующими и другими заболеваниями нервной системы | |
| EP4041226A1 (en) | Combinations of gaba-a receptor positive allosteric modulators and nmda antagonists, nmda negative allosteric modulators or nmda partial agonists | |
| Arun et al. | Comparative study of intranasal dexmedetomidine versus intranasal ketamine as premedicant in children | |
| CN115835862A (zh) | 治疗阿尔茨海默病的组合及其应用 | |
| JP2009508965A5 (enExample) | ||
| Holmes et al. | Central pontine myelinolysis in a patient with AIDS | |
| JP2015515971A5 (enExample) | ||
| JPWO2021201239A5 (enExample) | ||
| US20240238221A1 (en) | Tapentadol for treating neuropathic pain in covid-19 patients | |
| Song et al. | The Optimal Administration Time of Butorphanol in Suppressing Sufentanil-induced Cough: A Single-Center Randomized Double-Blind Trial | |
| JP2711776B2 (ja) | 顎関節症治療剤 | |
| Damghani et al. | The Analgesic Effects of Ketamine, Ketorolac and Dexamethasone after Adenotonsillectomy Surgery in Children Aged 4 to 18 Years. | |
| EP2437740A1 (en) | Treatment of tinnitus and associated auditory dysfunctions | |
| JPWO2020076809A5 (enExample) | ||
| JPWO2020018291A5 (enExample) |